Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump

Summary
Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump Reuters
Description from Reuters.
Who is covering this
-
Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump - Reuters
Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump Reuters
-
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.






